Vimarsana
Biggest News Aggregation in the World

Page 4 - Enavate Sciences News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Enavate Sciences. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Enavate Sciences Today - Breaking & Trending Today

Patient Square Capital Closes $3.9 Billion Inaugural Fund - Vimarsana News

Patient Square Capital Closes $3.9 Billion Inaugural Fund

FinSMEs is the financial news site dedicated to covering venture capital, private equity, and merger and acquisition deals in real time!

Patient Square Capital Announces Record $3.9 Billion Inaugural Fund - Vimarsana News

Patient Square Capital Announces Record $3.9 Billion Inaugural Fund

/PRNewswire/ -- Patient Square Capital ("Patient Square"), a leading health care investment firm, announced today that it closed its inaugural fund with...

Week In Review: Insilico Signs Six-Drug AI Discovery Deal With Sanofi Worth Up To $1.2 Bln - Vimarsana News

Week In Review: Insilico Signs Six-Drug AI Discovery Deal With Sanofi Worth Up To $1.2 Bln

Insilico Medicine signed a six-drug research collaboration with Sanofi. Wuhan Neurophth announced a $140 mn agreement to use Cyagen’s AI platform to discover novel AAV vectors.

Zenas BioPharma raises $118m Series B round to advance pipeline - Vimarsana News

Zenas BioPharma raises $118m Series B round to advance pipeline

US-based immune therapy developer Zenas has significant operations in China.

Edd Fleming, M.D., former Senior Partner at McKinsey and Company, joins Enavate Sciences as Executive Vice President, Commercialization - Vimarsana News

Edd Fleming, M.D., former Senior Partner at McKinsey and Company, joins Enavate Sciences as Executive Vice President, Commercialization

MENLO PARK, Calif., Nov. 10, 2022 /PRNewswire/ -- Enavate Sciences, a portfolio company of Patient Square Capital, is pleased to announce that H. ...